Envestnet Portfolio Solutions
ADMA icon

Envestnet Portfolio Solutions’s ADMA Biologics ADMA Stock Holding History

Envestnet Portfolio Solutions’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Sell
42,462
-78
-0.2% -$711 ﹤0.01% 1114
2026
Q1 		$383K Sell
42,540
-4,456
-9% -$70.3K ﹤0.01% 1006
2025
Q4 		$857K Buy
46,996
+9,275
+25% +$156K ﹤0.01% 811
2025
Q3 		$553K Sell
37,721
-1,363
-3% -$23.4K ﹤0.01% 986
2025
Q2 		$712K Buy
39,084
+26,982
+223% +$550K ﹤0.01% 937
2025
Q1 		$240K Buy
+12,102
New +$209K ﹤0.01% 1400

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Envestnet Portfolio Solutions's ADMA Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its ADMA Biologics (ADMA) stake by 0.18% in Q2 2026, selling an estimated $711 and leaving 42,462 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Envestnet Portfolio Solutions first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $857K in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Envestnet Portfolio Solutions held 42,462 shares of ADMA Biologics worth $355K as of Q2 2026.
  • Envestnet Portfolio Solutions sold 78 ADMA Biologics shares in Q2 2026, an estimated $711.
  • ADMA Biologics made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #1114 holding.
  • Envestnet Portfolio Solutions first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
  • Envestnet Portfolio Solutions's ADMA Biologics position peaked at $857K in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.